YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Anti-inflammatory Effect of Paeoniflorigenone Isolated from Paeoniae Radix

Paeoniflorigenone 작약성분의 항염효과

  • Kim, Ha-Yan (Department of ImmunoMicrobiology, College of Pharmacy, Dongduk Women's University) ;
  • Han, Yong-Moon (Department of ImmunoMicrobiology, College of Pharmacy, Dongduk Women's University)
  • 김하얀 (동덕여자대학교 약학대학 면역.미생물학교실) ;
  • 한용문 (동덕여자대학교 약학대학 면역.미생물학교실)
  • Received : 2012.01.19
  • Accepted : 2012.02.09
  • Published : 2012.02.29
Download PDF
⟨ Previous Next ⟩

Abstract

In Northeast Asia, Paeoniae Radix has been used in treatments of inflammation-causing diseases such as arthritis for many centuries. Paeoniflorin, one of the principle bioactive monoterpene glucosides from the paeony root, is reported to be mostly responsible for the effectiveness of the treatments. However, the anti-inflammatory effect of a monoterpene, paeoniflorigenone (PFG) which partially has the moiety of paeoniflorin minus a glucose structure is unknown. Thus, the aim of this work was to investigate anti-inflammatory activity of PFG. For the investigation, PFG activity on the NO (nitric oxide) production from LPS-stimulated macrophages, and the anti-inflammatory effect was tested in the animal model of septic arthritis caused by Candida albicans, a major etiological agent for septic arthritis. For induction of the arthritis, mice were administered with an emulsion of C. albicans cell wall (CACW) mixed with Complete Freund's Adjuvant (CFA) via footpad-injection (Day 0); PFG at a dose of 0.5 or 1 mg/mouse (25 or 50 mg/kg of body-weight) was given to the animals on Day 3, 6, and 9; footpads were scored for arthritis. Moreover, the PFG effect on proliferation of T-lymphocyte that causes aggravation of arthritis was additionally tested. Data resulting from those tests showed that PFG inhibited the NO production from the stimulated macrophage in a dose dependent manner (P<0.05), indicating that PFG is an anti-inflammatory. To confirm the in-vitro results, anti-inflammatory activity of PFG was determined against C. albicans-caused septic arthritis. Data showed that PFG-treatment reduced footpad-swelling which indicates that PFG has anti-arthritic effect (P<0.05), which is therapeutic. The anti-arthritic effect appeared to be mediated by PFG suppression of T-cell proliferation. Ultimately, PFG, a monoterpene component, has anti-inflammatory activity analogous to paeoniflorin. The anti-inflammatory activity treats the septic arthritis due to a pathogenic fungus C. albicans.

Keywords

References

  1. Zhu, L., Wei, W., Zheng, Y. Q. and Jia, X. Y. : Effects and mechanisms of total glucosides of paeony on joint damage in rat collagen-induced arthritis. Inflamm. Res. 54, 211 (2005).
  2. Koo, Y. K., Kim, J. M., Koo, J. Y., Kang, S. S., Kim, Y. S., Chung, J. H. and Yun-Choi, H. S. : Platelet anti-aggregatory and blood ant-coagulant effects of compounds ioslated from Paeonia lactiflora and Paeonia suffruticosa. Pharmazie. 65, 624 (2010).
  3. He, D. Y. and Dai, S. M. : Anti-inflammatory and immunomodulatory effects of Paeonia lactiflora Pall., a traditional Chinese herbal medicine. Ethnopharmacology 2, 1 (2011).
  4. Zheng, Y. Q. and Wei, W. : Total glucosides of paeony suppressed adjuvant arthritis in rats and intervening cytokinesignaling between different types of synoviocytes. Int. Immunopharmacol. 5, 1560 (2005).
  5. Chen, G., Guo, L. X., Deng, X. H., Yin, Z. Y., and Jing, J. J. : Effects of total glucosides of paeony on nitric oxide and inducible nitric oxide synthase production in macrophages and its mechanism. Zhongguo Mian Yi Xue Za Zhi. 24, 345 (2008).
  6. Liang, J. S., Chen, M. Z. and Xue, S. Y. : Effects of total glucosides of paeony on the function of peritoneal macrophages in rats. Zhongguo Mian Yi Xue Za Zhi. 4, 153 (1990).
  7. Kimura, M., Kimura, I., Nojima, H., Takahashi, K., Hayashi, T., Shimizu, M. and Morita, N. : Blocking effects of a new component, paeoniflorigenone, in paeony root on neuromuscular junctions of frogs and mice. Japan. J. Pharmacol. 35, 61 (1984).
  8. Shimizu, M., Hayashi, T., Morita, N., Kimura, I., Kimura, M., Kiuch, F., Noguchi, H., Itaka, Y. and Sankawa, U. : Paeoniflorigenone, a new monoterpene from paeony roots. Tetrahedron Lett. 22, 3069 (1981).
  9. Han Y. : Ginkgo terpene component has an anti-inflammatory effect on Candida albicans-caused arthritis. Int. Immunopharmacol. 5, 1049 (2005).
  10. Han, Y. : Rutinhas therapeutic effect on septic arthritis caused by Candida albicans. Int. Immunopharmacol. 9, 207 (2009).
  11. Miceli, M. H., Daz, J. A. and Lee, S. A. : Emergingopportunistic yeast infections. Lancet Infect. Dis. 11, 142-51 (2011).
  12. Cuende, E., Barbadillo, C. E., Mazzucchelli, R., Isasi, C., Trujillo, A. and Andreu, J. L. : Candida arthritis in adult patients who are not intravenous drug addicts: report of three cases and review of the literature. Semin Arthritis Rheum. 22, 224 (1993).
  13. Lerch, K., Kalteis, T., Schubert, T., Lehn, N. and Grifka, J. : Prosthetic joint infection with osteomyelitis due to Candida albicans. Mycoses. 46, 462 (2003).
  14. Azaceta, G., Olave. T., de los Martires, L. D., Delgado, C., Gutierrez, M. and Palomera, L. : Successful lipid-complexed amphotericin B treatment of Candida arthritis in a lymphoma patient. Rev. Rhum. Eng. 66, 434 (1999).
  15. Han, Y. and Cutler, J. E. : Antibody response that protects against disseminated candidiasis. Infect Immun. 63, 2714 (1995).
  16. Han, Y., Kozel, T. R., Zhang, M. X., MacGill, R. S., Carroll, M. C. and Cutler, J. E. : Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis. J. Immunol. 167, 1550 (2001).
  17. Pohlers, D., Nissler, K., Frey, O., Simon, J., Petrow, P. K., Kinne, R. W. and Brauer, R. : Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen-induced arthritis: influence on T helper cell activation. Clin. Exp. Immunol. 135, 409 (2004).
  18. Nissler, K., Pohlers, D., Hckel, M., Simon, J., Brauer, R. and Kinne, R. W. : Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: influence on macrophage activation. Ann. Rheum. Dis. 63, 1470 (2004).
  19. Nissler, K., Pohlers, D., Huckel, M., Simon, J., Brauer, R. and Kinne, R. W. : Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: influence on macrophage activation. Ann. Rheum. Dis. 63, 1470 (2004).
  20. Kinne, R. W., Brauer, R., Stuhlmuller, B., Palombo-kinne, E. and Burmester, G. R. : Macrophages in rheumatoid arthritis. Arthritis Res. 2, 189 (2000).
  21. Lotito, A. P., Muscara, M. N., Kiss, M. H., Teixeira, S. A., Novaes, G. S., Laurindo, I. M., Silva, C. A. and Mello, S. B. : Nitric oxide-derived species in synovial fluid from patients with juvenile idiopathic arthritis. Rheumatol. 31, 992 (2004).